Home » Peptide-based drugs

Peptide-based drugs

Peptide Drugs: From Scientific Research to Clinical Application

Peptides are an integral part of modern biotechnology and pharmaceutical science. Many innovative medicines used in clinical practice today are peptide-based. Peptides are chains of amino acids linked by peptide bonds, and their structure and function can closely resemble naturally occurring peptides found in the human body.

Peptide drugs are developed to target specific biological processes with high precision. Due to their exceptional specificity, they have become one of the fastest-growing areas of pharmaceutical research, with expanding applications in endocrinology, oncology, metabolic diseases, osteoporosis, and many other medical fields.

From Laboratory Research to an Approved Medicine

Every new peptide molecule begins its journey in the laboratory. During early research, scientists evaluate its chemical structure, stability, purity, biological activity, and interactions with various biological mechanisms.

Following laboratory studies, peptide candidates undergo preclinical testing and then multiple phases of clinical trials to assess their safety, efficacy, and quality. Only after successfully completing these stages and receiving approval from the relevant regulatory authorities can a peptide molecule be registered as a medicinal product.

This process often takes more than a decade and requires substantial scientific, technological, and financial investment.

Commonly Used Peptide Drugs

Modern medicine utilizes a wide range of peptide-based medicines, including:

  • Semaglutide – a GLP-1 receptor agonist used for the treatment of type 2 diabetes and, in certain cases, for chronic weight management.

  • Tirzepatide – a dual GIP and GLP-1 receptor agonist used for the treatment of type 2 diabetes and approved in certain markets for chronic weight management.

  • Liraglutide – a GLP-1 receptor agonist used to improve glycaemic control and, in certain cases, for weight management.

  • Dulaglutide – a long-acting GLP-1 receptor agonist used in the treatment of type 2 diabetes.

  • Exenatide – one of the first GLP-1 receptor agonists introduced into clinical practice.

  • Insulin – a naturally occurring peptide hormone that has been used for over a century to treat diabetes mellitus.

  • Teriparatide – a synthetic peptide used to treat certain forms of osteoporosis.

  • Oxytocin – a naturally occurring peptide hormone widely used in obstetrics.

  • Desmopressin – a synthetic analogue of vasopressin used to treat selected endocrine and haematological disorders.

The Importance of Scientific Research

Modern peptide medicines are the result of decades of scientific research. Every new peptide molecule undergoes a rigorous programme of testing and evaluation designed to ensure its quality, safety, and efficacy.

Research involving peptides contributes to a deeper understanding of biological processes and provides the foundation for the development of future therapeutic approaches.

Important Information

The information provided on this website is intended for educational and informational purposes only.

MedPeptides-UK supplies Research Use Only (RUO) products exclusively for scientific and laboratory research. These products are not approved medicinal products and are not intended for human or veterinary use, diagnosis, or treatment.